The STING pathway is indispensable in tumor treatment, as activation of STING has a synergizing effect on therapy in pancreatic cancer, whereas knockdown of STING or cGAS signaling is sufficient to abolish the efficacy of immune checkpoint inhibitors [32, 33]. This evidence concerns the gene STING1 and familial pancreatic carcinoma.